Foreword: this issue of the Seton Hall Law Review presents contributions to Preparing for Pharmaceutical Response to Pandemic Influenza, a two-day Symposium held at Seton hall University School of Law in the fall of 2008.
D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001717:Birds; D004196:Disease Outbreaks; D014943:Global Health; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D053124:Influenza A Virus, H5N1 Subtype; D007252:Influenza Vaccines; D005585:Influenza in Birds / Q000635:transmission; D007251:Influenza, Human / Q000635:transmission*; D053139:Oseltamivir / Q000008:administration & dosage / Q000600:supply & distribution / Q000627:therapeutic use; D014481:United States; D053243:Zanamivir / Q000008:administration & dosage / Q000600:supply & distribution / Q000627:therapeutic use
D000998:Antiviral Agents; D007252:Influenza Vaccines; D053139:Oseltamivir; D053243:Zanamivir